Drug Pipeline

XH001 Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-19 NCT07594964 To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as… Phase 1 Recruiting
Active Studies by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07329894 Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen… Gastrointestinal Cancer Recruiting
NCT07298200 Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection… Advanced Gastric Cancer Recruiting
NCT07594964 To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as… Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer) Recruiting
Sponsors Running XH001 Injection Trials
Jia Wei (1) Beijing GoBroad Hospital (1) Shenzhen Xinhe Biomedical (1)
Disease Areas
Gastric Cancer (2) Pancreatic Cancer (1) Liver Cancer (1) Bladder Cancer (1) Cholangiocarcinoma (1)
Get alerts when XH001 Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free